(Q52079961)

21 April 2018

title

Estimates of the lifetime costs of breast cancer treatment in Canada. (English)

1 reference

21 April 2018

0 references

Will BP

1

1 reference

21 April 2018

Berthelot JM

2

1 reference

21 April 2018

Le Petit C

3

1 reference

21 April 2018

Tomiak EM

4

1 reference

21 April 2018

Verma S

5

1 reference

21 April 2018

Evans WK

6

1 reference

21 April 2018

publication date

1 April 2000

1 reference

21 April 2018

European Journal of Cancer

published in

1 reference

21 April 2018

volume

36

1 reference

21 April 2018

page(s)

724-735

1 reference

21 April 2018

issue

6

1 reference

21 April 2018

Cost-of-illness studies: a major headache?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Multidisciplinary management of advanced primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

ABC of breast diseases. Metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

The cost of radiotherapy at an Ontario regional cancer centre: a re-evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Estimating the treatment costs of breast and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

The costs of treating breast cancer in the United Kingdom: implications for screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

The cost of breast cancer recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

The costs of treating breast cancer in Australia and the implications for breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Advanced breast cancer: use of resources and cost implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

Indirect costs in economic studies: confronting the confusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900340-8

7 January 2021

10.1016/S0959-8049(99)00340-8

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

10762744

1 reference

21 April 2018